| Date |
Title |
| Jul 2022 |
Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model |
|
| May 2022 |
A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation |
|
| Feb 2022 |
Intramuscular and intratendinous placenta-derived mesenchymal stromal-like cell treatment of a chronic quadriceps tendon rupture |
|
| Jan 2021 |
Perinatal Cells: A Promising COVID-19 Therapy? |
|
| Sep 2020 |
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019 |
|
| Jan 2020 |
Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine |
|
| Aug 2019 |
Use of Human Placenta-Derived Cells in a Preclinical Model of Tendon Injury |
|
| Jan 2019 |
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial |
|
| Nov 2018 |
Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18 |
|
| Oct 2018 |
Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells |
|
| Oct 2018 |
Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function |
|
| Feb 2018 |
Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model |
|
| Jan 2018 |
Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models |
|
| Dec 2017 |
Placenta-derived PLX-PAD mesenchymal-like stromal cells are efficacious in rescuing blood flow in hind limb ischemia mouse model by a dose- and site-dependen |
|
| Oct 2017 |
Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance |
|
| Feb 2016 |
Human placenta-derived stromal cells decrease inflammation, placental injury and blood pressure in hypertensive pregnant mice |
|
| Oct 2015 |
In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications |
|
| Sep 2015 |
Mesenchymal Stromal Cells Prevent Allostimulation in vivo and Control CheckPoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation |
|
| Aug 2015 |
Concise Review: Process Development Considerations for Cell Therapy |
|
| Aug 2015 |
Critical elements in the development of cell therapy potency assays for ischemic conditions |
|
| Dec 2014 |
Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal 2 cells confer neuroprotection to nerve growth factor (NGF)-differentiated 3 PC12 cells exposed to ischemia by secretion of IL-6 and VEGF |
|
| Mar 2014 |
Could Placental Cell Therapy be a Preemptive Approach to Protecting Women from Disabling Strokes? |
|
| Mar 2014 |
CELL THERAPIES – The Challenges & Possible Solutions for Transferring Cell Therapy From the Bench to the Industry |
|
| Nov 2013 |
Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model |
|
| Oct 2013 |
Self Healing- Article from European Biopharmaceutical Review |
|
| Oct 2013 |
Cell Therapy: Pushing Cells Around |
|
| Oct 2013 |
Commentary: A guide for potency assay development of cell-based product candidates |
|
| Jun 2013 |
Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells |
|
| Oct 2011 |
Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS) |
|
| Feb 2010 |
Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats |
|
| Feb 2010 |
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table |
|
| Jun 2009 |
The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia |
|
| May 2009 |
Safety and Biodistribution Profile of Placental-derived Mesenchymal Stromal Cells (PLX-PAD) Following Intramuscular Delivery |
|
| Apr 2009 |
Cytokines as the Major Mechanism of MSC Clinical Activity: Expanding the Spectrum of Cell Therapy |
|
| Aug 2008 |
Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood |
|
